FDA approves generic valsartan amid drug shortage
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages…
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann (Reuters) – The U.S. Food and Drug…
Abercrombie expects redesigned stores to boost 2019 sales, shares surge
(Reuters) – Abercrombie & Fitch’s shares surged 20 percent after the apparel retailer forecast better-than-expected annual sales on Wednesday, betting on its remodeled stores and the popularity of its Hollister…
J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on…
Allergan’s add-on treatment for depression fails late-stage studies
FILE PHOTO: The Allergan logo is seen in this photo illustration November 23, 2015. To match special report USA-FDA/CASES REUTERS/Thomas White/Illustration/File Photo (Reuters) – Allergan Plc said on Wednesday its…
GE’s CEO warns of negative industrial cash flow in 2019, shares drop
(Reuters) – General Electric Co’s chief executive surprised investors on Tuesday by forecasting a net cash outflow from its industrial businesses this year mainly due to its ailing power-plant unit,…
Wall Street drops after weak data, healthcare slump
(Reuters) – Wall Street’s major indexes fell on Monday, weighed down by a weak U.S. construction spending report and declines in healthcare shares, as an initial rally on optimism over…
Musk says $35,000 Model 3 to reach volume production mid-year
SpaceX founder Elon Musk looks on at a post-launch news conference after the SpaceX Falcon 9 rocket, carrying the Crew Dragon spacecraft, lifted off on an uncrewed test flight to…
Eli Lilly seeks to quell drug price anger with cheaper insulin
(Reuters) – Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in…
New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India’s Hetero Labs Ltd a day earlier, adding to…